Florence Boissière-Michot

11PUBLICATIONS
53CO-AUTHORS
Tumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Midwifery not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 31, 2024
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer.

Davide Massa, Claudio Vernieri, Lorenzo Nicolè

|Oct 28, 2023
Prognostic Relevance of Tumor-Infiltrating Immune Cells in Cervix Squamous Cell Carcinoma.

Carl Mathis Wild, Fabian Garrido, Christian Dannecker

|Oct 14, 2022
Association of CD206 Protein Expression with Immune Infiltration and Prognosis in Patients with Triple-Negative Breast Cancer.

Angélique Bobrie, Océane Massol, Jeanne Ramos

|Oct 14, 2022
Prognostic Relevance of Nuclear Receptors in Relation to Peritumoral Inflammation and Tumor Infiltration by Lymphocytes in Breast Cancer.

Melitta B Köpke, Marie-Christine Chateau, Florence Boissière-Michot

|May 28, 2022
Investigation of Molecular Features Involved in Clinical Responses and Survival in Advanced Endometrial Carcinoma Treated by Hormone Therapy.

Mathias Neron, Arnaud Guille, Lucie Allegre

|Dec 10, 2021
Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers.

William Jacot, Aurélie Maran-Gonzalez, Océane Massol

Pageof 2

Frequent Collaborators

6 joint publications

William Jacot

4 joint publications

Caroline Mollevi

3 joint publications

Vincent Cavaillès

3 joint publications

Evelyne Lopez-Crapez